USE OF THE PROGNOSTIC 40-GENE EXPRESSION PROFILE TEST (40-GEP) IMPROVES METASTASIS RISK PREDICTION OF HIGH-RISK CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Skin Cancers
Ashley Wysong, MD, MS1; Ally Khan Somani, MD, PhD2; Sarah T Arron, MD, PhD3; Javier Cañueto, MD, PhD4; Alison L Fitzgerald, PhD5; Jennifer J Siegel, PhD5; Sarah J Kurley, PhD5; Anesh Prasai, PhD5; Julia M Kasprzak, MD6; Jason G Newman, MD, FACS7
1Department of Dermatology, University of Nebraska Medical Center, Omaha, Nebraska, USA; 2Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, USA; 3Peninsula Dermatology, Burlingame, California, USA; 4Department of Dermatology, Universitario de Salamanca, Salamanca, Spain; 5Research and Development, Castle Biosciences, Inc., Friendswood, Texas, USA; 6Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA; 7Department of Otolaryngology Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina